Aegerion Pharmaceuticals, Inc. (AEGR) [Rocket]

In millions, except per share items	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09	Dec-31-08
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
United States	214.6	143.4	42.3
BRAZIL	15.0	11.1	6.0
Other	10.3	3.9	0.2
Total revenues	239.9	158.4	48.5	0.0	0.0	0.0	7.0	17.7
Revenue growth [+]	51.5%	226.2%				-100.0%	-60.2%	30.8%
United States	49.7%	239.0%
BRAZIL	35.3%	84.2%
Cost of goods sold	52.3	14.4	5.0	0.0	0.0	0.0	14.1	17.7
Gross profit	187.6	144.0	43.5	0.0	0.0	0.0	-7.0	0.0
Gross margin	78.2%	90.9%	89.7%				-100.0%	0.0%
Selling, general and administrative [+]	187.9	132.7	76.1	34.1	14.0	5.9	3.1	5.2
General and administrative							3.1	5.2
Research and development	44.9	38.0	29.8	25.2	24.4	7.6
Other operating expenses								17.7
EBITDA [+]	-23.2	-24.4	-60.0	-58.0	-38.0	-13.5	-10.1	-22.9
EBITDA growth	-5.0%	-59.3%	3.4%	52.7%	180.6%	34.2%	-55.9%	16.6%
EBITDA margin	-9.7%	-15.4%	-123.5%				-143.3%	-129.1%
Depreciation	1.8	1.2	0.5	0.2	0.0	0.0	0.0	0.0
EBITA	-25.0	-25.6	-60.4	-58.2	-38.0	-13.6	-10.1	-22.9
EBITA margin	-10.4%	-16.2%	-124.5%				-143.7%	-129.3%
Amortization of intangibles	20.2	1.1	1.9	1.0	0.4
EBIT [+]	-45.2	-26.7	-62.3	-59.2	-38.4	-13.6	-10.1	-22.9
EBIT growth	69.2%	-57.2%	5.2%	54.3%	183.4%	34.0%	-55.8%	16.7%
EBIT margin	-18.8%	-16.9%	-128.4%				-143.7%	-129.3%
Non-recurring items				1.4	0.9
Interest expense, net [+]	27.6	9.7	0.5	0.8	0.9	2.3	1.9	0.6
Interest expense	27.6	9.7	0.5	0.9	1.1	2.4	2.1	1.1
Interest income				0.2	0.2	0.1	0.2	0.5
Other income (expense), net [+]	1.2	-2.1	-0.2	-0.9	0.7	-0.2	-0.2	-1.5
Other	1.2	-2.1	-0.2	-0.9	0.7	0.2
Pre-tax income	-71.6	-38.5	-63.0	-62.3	-39.5	-16.0	-12.2	-25.0
Income taxes	1.8	0.9	0.3	0.0	0.0	-1.8	0.0	0.0
Tax rate				0.0%	0.0%	11.2%	0.0%	0.0%
Net income	-73.3	-39.4	-63.4	-62.3	-39.5	-23.0	-12.2	-25.0
Net margin	-30.6%	-24.9%	-130.5%				-173.2%	-141.3%

Basic EPS [+]	($2.55)	($1.35)	($2.19)	($2.64)	($2.03)	($5.07)	($7.36)	($0.02)
Growth	88.6%	-38.3%	-17.0%	29.9%	-59.9%	-31.1%	43871.1%	3.2%
Diluted EPS [+]	($2.55)	($1.35)	($2.19)	($2.64)	($2.03)	($5.07)	($7.36)	($0.02)
Growth	88.6%	-38.3%	-17.0%	29.9%	-59.9%	-31.1%	43871.1%	3.2%

Shares outstanding (basic) [+]	28.7	29.1	28.9	23.6	19.4	4.5	1.7	1,495.4
Growth	-1.3%	0.7%	22.6%	21.4%	327.8%	173.9%	-99.9%	20.1%
Shares outstanding (diluted) [+]	28.7	29.1	28.9	23.6	19.4	4.5	1.7	1,495.4
Growth	-1.3%	0.7%	22.6%	21.4%	327.8%	173.9%	-99.9%	20.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.